-
Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth.
Subramaniam GA, Warden D, Minhajuddin A, Fishman MJ, Stitzer ML, Adinoff BH, Trivedi MH, Weiss RD, Potter JS, Poole SA, Woody GE. Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth. Journal of the American Academy of Child and Adolescent Psychiatry 2001;50(11):1120-1128.
-
Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems.
Ghitza UE, Sparenborg S, Tai B. Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems. Substance Abuse and Rehabilitation 2011:2:125-131.
-
Randomized controlled trial of osmotic-release methylphenidate with CBT in adolescents with ADHD and substance use disorders.
Riggs PD, Winhusen TJ, Davies RD, Leimberger JD, Mikulich-Gilbertson SK, Klein C, Macdonald M, Bailey GL, Haynes LF, Jaffee WB, Haminton N, Hodgkins CG, Whitmore E, Trello-Rishel K, Tamm L, Acosta MC, Royer-Malvestuto C, Subramaniam GA, Fishman MJ, Holmes BW, Kaye ME, Vargo MA, Woody GE, Nunes EV, Liu DS. Randomized controlled trial of osmotic-release methylphenidate with CBT in adolescents with ADHD and substance use disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2011;50(9):903-914.
-
Brief strategic family therapy versus treatment as usual: Results of a multisite randomized trial for substance using adolescents.
Robbins MS, Feaster DJ, Horigian VE, Rohrbaugh MJ, Shoham V, Bachrach K, Miller M, Burlew AK, Hodgkins C, Carrion IS, Vandermark N, Schindler E, Werstlein R, Szapocznik J. Brief strategic family therapy versus treatment as usual: Results of a multisite randomized trial for substance using adolescents. Journal of Consulting and Clinical Psychology 2011;79(6):713-727.
-
Community providers’ impression of HIV prevention intervention research in NIDA’s Clinical Trials Network.
Campbell ANC, Hartzler B, Hatch-Maillette MA, Calsyn DA, Miele GM, Tross S. Community providers' impression of HIV prevention intervention research in NIDA's Clinical Trials Network. Journal of Drug Issues 2011;41(4):441-460.
-
Female condom skill and attitude: Results from a NIDA Clinical Trials Network gender-specific HIV risk reduction study.
Campbell ANC, Tross S, Hu M, Pavlicova M, Kenney J, Nunes EV. Female condom skill and attitude: Results from a NIDA Clinical Trials Network gender-specific HIV risk reduction study. AIDS Education and Prevention 2011; 23(4):328-339.
-
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial.
Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Garden J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer JA, Somoza EC, Sonne SC, Ling W. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry 2011;68(12):1238-1246.
-
Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention deficit hyperactivity disorder (ADHD).
Winhusen TJ, Lewis DF, Riggs PD, Davies RD, Adler LA, Sonne SC, Somoza EC. Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention deficit hyperactivity disorder (ADHD). Journal of Child and Adolescent Psychopharmacology 2011;21(5):455-463.
-
Divergence by ADHD subtype in smoking cessation response to OROS-methylphenidate.
Covey LS, Hu M, Weissman J, Croghan IT, Adler LA, Winhusen TJ. Divergence by ADHD Subtype in Smoking Cessation Response to OROS-Methylphenidate. Nicotine and Tobacco Research 2011;13(10):1003-1008.
-
A combined group and individual 12-step facilitative intervention targeting stimulant abuse in the NIDA Clinical Trials Network: STAGE-12.
Daley DC, Baker S, Donovan DM, Hodgkins CC, Perl HI. A combined group and individual 12-step facilitative intervention targeting stimulant abuse in the NIDA Clinical Trials Network: STAGE-12. Journal of Groups in Addiction and Recovery 2011;6(3):228-244.